What DNAnexus does

DNAnexus is a private, U.S.-based (San Francisco) cloud-software company founded in 2009 that operates the Precision Health Data Cloud, an enterprise platform for managing, analyzing, and collaborating on multiomics and clinical data across pharmaceutical and biotech companies, clinical diagnostics labs, academic medical centers, biobanks and population health programs, commercial real-world data businesses, and regulatory agencies such as the FDA. The platform is hosted on AWS and Microsoft Azure, encrypts sequence data with AES-256, and is certified or aligned to ISO 27001, NIST 800, HIPAA, GDPR, GxP/ICH, CAP/CLIA, FedRAMP, and 21 CFR Parts 11 and 820; it supports workflow orchestration across Nextflow, WDL, and Docker, embedded JupyterLab notebooks backed by Spark clusters (with R, SQL, TensorFlow, and PyTorch), a population-scale cohort browser used for the 500,000-participant UK Biobank dataset, and white-label Trusted Research Environments (including the UK Biobank RAP, Our Future Health TRE, and FDA precisionFDA).

The company's commercial offering is anchored by the Precision Health Data Cloud SaaS subscription, supplemented by Professional Services (implementation, GxP readiness, pipeline migration, AI/ML deployment), Managed Services (ongoing platform administration and bioinformatics), and usage-based cloud compute and storage on AWS and Azure. Distribution combines a high-touch enterprise field-sales motion ('Request a Demo', 'Schedule a Scientific Consultation') with multi-tier channel partnerships — the three major hyperscalers (AWS, Microsoft, Oracle), services and consulting partners (Accenture, Zifo, Epista, DataXight), technology partners (NVIDIA, Panomics, Fabric Genomics, Intelliseq, LORENZ), instrument partners (PacBio, Element Biosciences), and biobank/data partners (UK Biobank, Our Future Health, Ovation, TMA Precision Health). In March 2022, DNAnexus closed a $200 million funding round led by Blackstone Growth to fund global expansion and AI/ML integration; the company has since productized AI through the 2026 Innovation Hub (Omics Data Agent, AutoML Assistant, Omics Data Catalog) and packaged Solutions Packages for pharma and diagnostics, while expanding into new disease areas (multiple sclerosis, ALS, muscular dystrophy) and the U.S./European regulatory collaboration market through Trusted Regulatory Spaces and Project PRISM.

Name

DNAnexus

Legal name

DNAnexus, Inc.

Website

https://dnanexus.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

251–500 employees

Short description

DNAnexus provides the Precision Health Data Cloud, an enterprise SaaS platform for managing, analyzing, and collaborating on multiomics and clinical data, serving pharmaceutical, biotech, diagnostics, academic medical centers, biobanks, and regulatory customers globally.

Ownership category

akta.pro rank

Product category

Cloud-based biomedical data analytics platform (Precision Health Data Cloud)

NAICS

Computer Systems Design and Related Services (54151)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)

akta.pro secondary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

Keywords

• Precision health cloud
• Multiomics data platform
• Biomedical data analytics
• Clinical genomics software
• Trusted research environment

Headquarters

HQ city

Mountain View

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations

Revenue model

1. Platform Subscription (Precision Health Data Cloud SaaS): Recurring subscription revenue from enterprise customers (pharma, biotech, diagnostics, medical centers, biobanks, regulatory) accessing the Precision Health Data Cloud SaaS platform hosted on AWS and Azure with role-based access, GxP-compliance, and analytics tooling.
2. Professional Services: Implementation, custom application development, pipeline migration/optimization, GxP readiness support, bioinformatics expertise, multiomics insight generation, and AI/ML deployment services — sold alongside platform subscriptions.
3. Managed Services: Ongoing post-go-live management of customer DNAnexus systems, including platform configuration, administration, bioinformatics pipeline development, structural variant analysis, and multiomics insights generation.
4. Usage-Based Cloud Compute & Storage: Consumption-based revenue tied to on-demand compute and storage services on AWS and Microsoft Azure, with role-based user management and spend/usage visibility features for customers.
5. Data Enablement / B2B Data Sharing: Revenue from data providers and real-world data businesses using DNAnexus as a Trusted Research Environment to package, dispense, and monetize clinico-multiomic datasets to commercial clients.

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels11 records

Core offering

DNAnexus develops and operates the Precision Health Data Cloud, a SaaS platform hosted on AWS and Microsoft Azure that lets pharmaceutical, biotech, clinical diagnostics, biobank, and academic medical center customers store, analyze, and collaborate on multimodal omics and clinical data. The platform bundles bioinformatics pipelines, AI/ML tooling, a population-scale cohort browser, embedded JupyterLab with Spark, and compliance certifications (GxP, FedRAMP, HIPAA, GDPR, ISO 27001, CAP/CLIA), with attached Professional Services and Managed Services for implementation, GxP readiness, and ongoing operations.

Product overview

DNAnexus offers the Precision Health Data Cloud as a unified enterprise platform with modular add-ons and packaged solutions. At its core is the DNAnexus Platform for managing, analyzing, and collaborating on multiomics and clinical data, complemented by the Trusted Regulatory Spaces (TRS) module for regulatory workflows. The Innovation Hub adds specialized AI-powered modules including the Omics Data Agent (GenAI virtual assistant), AutoML Assistant (conversational copilot), and Omics Data Catalog. Bundled Solutions Packages include the Omics Accelerator, Production Scaler, Next Gen Therapeutics Accelerator, Pre-Built Analysis Accelerators, and Molecular Testing Engine. Co-developed platforms include the UK Biobank Research Analysis Platform (RAP), EpiCypher CUTANA Cloud (powered by DNAnexus), City of Hope's POSEIDON precision oncology platform, and the FDA's precisionFDA Collaborative Omics Environment. Industry solutions span Pharmaceutical & Biotech, Academic Medical Centers, Clinical Diagnostics, Commercial Data Businesses, Biobanks & Population Programs, and Regulatory Solutions. The offering is supported by Professional Services, Managed Services, Solution Acceleration, and Training and Support.

Differentiator

Problem solved

Functional benefit

Brands

• Precision Health Data Cloud: The DNAnexus enterprise orchestration platform for precision health, marketed as 'The Precision Health Data Cloud' and serving as the umbrella product offering.
• DNAnexus Innovation Hub

Products and services

• DNAnexus Precision Health Data Cloud Platform
• DNAnexus Trusted Regulatory Spaces (TRS)
• Omics Accelerator
• Production Scaler
• Next Gen Therapeutics Accelerator
• Pre-Built Analysis Accelerators
• Molecular Testing Engine
• Omics Data Agent
• AutoML Assistant
• Omics Data Catalog
• DNAnexus Professional Services
• DNAnexus Managed Services

Named customers30 records

Segments7 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability10 records

Feature8 records

Partnerships

26 partnerships are on record, tiered core technology partner, flagship strategic partner, flagship cloud partner, core strategic partner, core services partner, flagship data/biobank partner, core data partner, core instrument partner and strategic partner.

• Intelliseqcore technology partnerTechnology or Integration · 1 January 2024Intelliseq (Poland-based) and DNAnexus have partnered to simplify and accelerate variant interpretation and clinical reporting. The integrated one-click solution streamlines NGS data analysis and helps scientists generate insights into somatic cancers, hereditary diseases, and other precision medicine applications. Announced in January 2024.
• U.S. Food and Drug Administration (FDA)flagship strategic partnerStrategic or Co-development Partner · 1 December 2019FDA selected DNAnexus to power the precisionFDA Collaborative Omics Environment in the Cloud under a five-year, $20 million contract awarded in December 2019. The partnership enables FDA to enhance precisionFDA capabilities for sponsor-reviewer interaction, add support for multi-omics, and provide a library of analytical, statistical, and machine learning applications.
• Oracleflagship cloud partnerTechnology or IntegrationDNAnexus teamed up with Oracle to advance precision health by connecting respective ecosystems, making the DNAnexus platform seamlessly available to global Oracle Cloud Infrastructure, Oracle Health, and Oracle Database customers. Per 2026 industry coverage, DNAnexus and Oracle Health collaborated in September 2025 to link genomic data to electronic health records.
• Amazon Web Services (AWS)flagship cloud partnerTechnology or IntegrationAWS is a strategic Technology Alliance partner of DNAnexus. Together they provide joint customers with the ability to accelerate research, foster collaboration, and deliver better outcomes. DNAnexus stores customer sequence data and account information on AWS cloud servers using AES-256 encryption.
• Microsoftflagship cloud partnerTechnology or IntegrationMicrosoft and DNAnexus empower organizations to re-envision how they bring together people, data, and processes to better engage patients and optimize clinical and operational effectiveness. DNAnexus stores customer sequence data and account information on Microsoft Azure cloud servers using AES-256 encryption.
• Panomicscore technology partnerTechnology or IntegrationPanomics brings advanced additional multiomics analysis to DNAnexus, with biologist-friendly tools for transcriptomics and proteomics, interactive data exploration, and capabilities like gene co-perturbation and similarity search. The combination helps life sciences organizations accelerate biomarker discovery, drug repurposing, and precision medicine research.
• NVIDIAcore technology partnerTechnology or IntegrationNVIDIA partners with DNAnexus to accelerate time to value for scientific research. DNAnexus makes it easy to run NVIDIA Parabricks pipelines by providing an out-of-the-box solution.
• Fabric Genomicscore technology partnerTechnology or IntegrationFabric Genomics and DNAnexus have partnered to provide a push-button solution to interpret genomic sequences, detect clinically meaningful variants, and generate comprehensive patient reports. The workflow reduces overall analysis costs and significantly improves turnaround times from days to hours for clinical rare genetic disorders and oncology diagnostics (announcement Nov 2023).
• Lorenz Life Sciences (LORENZ)core technology partnerTechnology or IntegrationLorenz Life Sciences and DNAnexus have partnered to offer Trusted Regulatory Spaces — secure, cloud-native environments that improve the submission validation process and ease of sponsor-reviewer communication for human drug and biologics applications to health authorities. The companies have joined industry leaders and FDA on Project PRISM to advance solutions for submission, review, and communication.
• Veeva Systemscore strategic partnerStrategic or Co-development PartnerDNAnexus expanded its relationship with Veeva to advance global regulatory collaboration. The companies come together to connect sponsors, agencies, and standards development organizations on a regulatory collaboration cloud.
• DataXightcore services partnerImplementation/ SI/ Consulting PartnerDataXight is a full-service professional services organization that brings expertise across bioinformatics, artificial intelligence, large-scale data platforms, and product innovation. They offer end-to-end services including data services and strategy, advanced analytics workflows, and scientific decision support.
• Zifo Technologiescore services partnerImplementation/ SI/ Consulting PartnerZifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms.
• Epista Life Sciencecore services partnerImplementation/ SI/ Consulting PartnerEpista Life Science provides leading consulting services across the product development lifecycle for system implementations and advisory support. With strong expertise in Regulatory, Clinical, and Quality domains, Epista is the preferred partner for Trusted Regulatory Space deployment.
• Accenturecore services partnerImplementation/ SI/ Consulting PartnerAccenture is a leading global professional services company that helps the world's leading businesses, governments, and other organizations build their digital core, optimize their operations, accelerate revenue growth, and enhance citizen services — creating tangible value at speed and scale.
• Our Future Healthflagship data/biobank partnerStrategic or Co-development PartnerDNAnexus has been selected as the platform provider of the Trusted Research Environment for Our Future Health, the United Kingdom's largest health research program — a collaboration between the public, private, and charity sectors aimed at preventing, detecting, and treating disease.
• UK Biobankflagship data/biobank partnerStrategic or Co-development PartnerThe UK Biobank Research Analysis Platform (RAP), enabled by DNAnexus, exponentially increases the scale and accessibility of the world's largest and most comprehensive biomedical database for researchers around the world to advance understanding of human disease. UK Biobank contains in-depth genetic and health information from 500,000 UK participants.
• Ovationcore data partnerStrategic or Co-development PartnerOvation is a clinicogenomic data company committed to unlocking the potential of human genomic data to accelerate precision medicine. DNAnexus and Ovation teamed up to unlock large-scale precision health datasets to accelerate drug discovery.
• TMA Precision Healthcore data partnerStrategic or Co-development PartnerTMA Precision Health and DNAnexus have partnered to advance basic and translational research for patients who have a rare disease. Qualified researchers can use the DNAnexus Precision Health Data Cloud to access and explore TMA's high-quality whole genome sequencing data and associated longitudinal medical records.
• PacBiocore instrument partnerOEM/ Whitelabel/ Licensing PartnerPacBio is a premier life science technology company designing, developing, and manufacturing advanced sequencing solutions. DNAnexus and PacBio have collaborated to accelerate PacBio workflows on DNAnexus with Sentieon, with joint webinar content.
• Element Biosciencescore instrument partnerOEM/ Whitelabel/ Licensing PartnerElement Biosciences is developing disruptive DNA sequencing and other omics technology for research and diagnostic markets. DNAnexus and Element Biosciences have partnered to allow customers to stream data from Element's AVITI System directly to their DNAnexus account, combining unmatched AVITI sequencing performance with the DNAnexus multi-omic analysis platform.
• EpiCyphercore technology partnerTechnology or IntegrationEpiCypher launched CUTANA Cloud, a powerful epigenomic data analysis platform powered by DNAnexus that accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag. The platform was announced in November 2025.
• BigOmicscore technology partnerTechnology or IntegrationDNAnexus and BigOmics partner to provide seamless omics analysis through a joint solution brief for biotech and pharma customers.
• Boehringer Ingelheimflagship strategic partnerStrategic or Co-development PartnerBoehringer Ingelheim and DNAnexus are 2025 Prix Galien USA finalists for Best Digital Health Solution. Vada Perkins, VP & Global Head of Regulatory Intelligence & Policy at Boehringer Ingelheim, collaborates with DNAnexus on Trusted Regulatory Spaces and Cloud Transformation webinars.
• Accelerated Cure Project for MSstrategic partnerStrategic or Co-development PartnerAccelerated Cure Project for MS (ACP) launched the ACP Data Challenge Pilot, a new initiative inviting researchers to interrogate ACP's longitudinal and multi-omic MS data in a single secure DNAnexus-powered environment (announced June 2026).
• Longitude Prize on ALSstrategic partnerStrategic or Co-development PartnerLongitude Prize on ALS Discovery Award selections include 20 multidisciplinary teams using cutting-edge AI on DNAnexus-powered Prize datasets. Discovery Awardees were awarded £100,000 each plus access to the Prize datasets and a technical support package to drive computational work.
• ARPA-Hflagship strategic partnerStrategic or Co-development PartnerARPA-H pioneers adaptive cancer treatment, leveraging DNAnexus technology. Featured as one of the trusted biomedical leaders on the DNAnexus homepage.

Scale indicators12 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• AWS HealthOmics: AWS HealthOmics provides managed genomics and multiomics storage and workflow services natively on AWS — the same cloud DNAnexus runs on — and represents both a partner and a potential disintermediator for less-regulated workloads.
• Illumina Connected Analytics: Illumina, the dominant sequencing instrument vendor, offers Connected Analytics and DRAGEN-based cloud pipelines that overlap DNAnexus's NGS secondary analysis and multiomics workflows as part of a broader sequencing ecosystem.
• Microsoft Azure Health Data Services: Microsoft Azure Health Data Services offers cloud-based healthcare and life sciences data services natively on Azure, competing and partnering with DNAnexus across pharma R&D and clinical genomics workloads.
• Databricks (Healthcare & Life Sciences): Databricks' Healthcare & Life Sciences Lakehouse competes with DNAnexus for pharma R&D data unification, ML on multiomics, and collaborative analysis — at a broader, less biomedical-specialized level.

Emerging players

• Owkin: Owkin applies federated AI to clinical and omics data for biopharma and academic medical centers, intersecting DNAnexus's territory in AI-enabled translational research and multimodal data collaboration.
• Form Bio (subsidiary of DNA Script): Form Bio provides a cloud-based computational platform for genomics and synthetic biology data, with partial overlap to DNAnexus in NGS pipelines, multiomics analysis, and pharma R&D tooling.

Direct peers

• BC Platforms: BC Platforms provides a genomics and real-world data platform used by biobanks, pharma, and healthcare systems, with a comparable Trusted Research Environment and B2B data monetization model.
• Lifebit: Lifebit builds a cloud-based biomedical data platform (Lifebit CloudOS) for federated genomics and multi-omics analysis, directly competing with DNAnexus Precision Health Data Cloud for pharma, biobank, and translational research customers.
• Velsera (formerly Seven Bridges Genomics): Velsera operates the Seven Bridges Platform for biomedical data analysis and clinical interpretation, overlapping DNAnexus in NGS analysis, multiomics workflows, and pharma/biopharma translational research customers.
• SOPHiA GENETICS: SOPHiA GENETICS offers the SOPHiA DDM Platform for genomics data analysis and clinical decision support, competing directly in clinical diagnostics, NGS interpretation, and hospital lab workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/dnanexus
• YouTubeyoutube.com/@Dnanexus
• LinkedInlinkedin.com/company/dnanexus
• Facebookfacebook.com/223138427780595

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds9 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DNAnexus